Indianapolis, IN, United States of America

Sherryl L Lifer


Average Co-Inventor Count = 9.1

ph-index = 5

Forward Citations = 145(Granted Patents)


Company Filing History:


Years Active: 1991-1997

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Sherryl L Lifer: A Trailblazer in Pharmaceutical Innovations

Introduction

Sherryl L Lifer, based in Indianapolis, IN, is an accomplished inventor with a remarkable portfolio comprising ten patents. Her work primarily focuses on developing innovative pharmaceutical solutions that address critical health challenges. As a dedicated member of Eli Lilly and Company, Sherryl has made significant contributions to the field of drug discovery and development.

Latest Patents

Among her notable inventions are advancements in angiotensin II antagonists. These inventions introduce novel heterocyclic derivatives, their pharmaceutical formulations, and strategies for antagonizing angiotensin II receptors in mammals. This groundbreaking work has the potential to impact the treatment of various cardiovascular conditions, showcasing her expertise in pharmaceutical chemistry.

Career Highlights

Sherryl L Lifer has established a prominent career at Eli Lilly and Company, where she has been instrumental in driving innovation within the organization. Her dedication to research and development has positioned her as a valuable asset in the pharmaceutical industry. With a total of ten patents to her name, Sherryl's work reflects her commitment to improving health outcomes through innovative therapies.

Collaborations

Throughout her career, Sherryl has collaborated with esteemed colleagues, including Winston S Marshall and Jon Kevin Reel. These collaborations have fostered a dynamic research environment, leading to the advancement of cutting-edge pharmaceutical technologies and enhancing the collective impact of their inventions on healthcare.

Conclusion

Sherryl L Lifer's contributions to the pharmaceutical field through her inventive spirit and collaborative efforts exemplify the essence of innovation. Her patents, particularly in the area of angiotensin II antagonists, not only demonstrate her expertise but also hold promise for significant advancements in medical treatments. As she continues her work at Eli Lilly and Company, the medical community anticipates further contributions from this remarkable inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…